Asymmetric dimethylarginine (ADMA): Is really a biomarker for cardiovascular prognosis?

被引：10
|
作者：
Tousoulis, Dimitris [1 ]
Siasos, Gerasimos [1 ,2 ]
Oikonomou, Evangelos [1 ]
Stougianos, Pavlos [2 ]
Papageorgiou, Nikolaos [1 ]
机构：
[1] Univ Athens, Sch Med, Hippokrat Hosp, Cardiol Dept 1, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2011年 / 153卷 / 02期
关键词：
Asymmetric dimethylarginine; Biomarker; Cardiovascular disease; Atherosclerosis; CORONARY-ARTERY-DISEASE; STAGE RENAL-DISEASE; L-ARGININE; PLASMA-LEVELS; RISK; EVENTS; MORTALITY; MARKER; DEATH;
D O I：
10.1016/j.ijcard.2011.08.070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：123 / 125
页数：3
相关论文
共 50 条
  • [1] Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?
    Bouras, Georgios
    Deftereos, Spyridon
    Tousoulis, Dimitrios
    Giannopoulos, Georgios
    Chatzis, Georgios
    Tsounis, Dimitrios
    Cleman, Michael W.
    Stefanadis, Christodoulos
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (02) : 180 - 200
  • [2] Asymmetric Dimethylarginine (ADMA) in cardiovascular and renal disease
    Alpoim, Patricia Nessralla
    Nunes Sousa, Leticia Parreiras
    Lucas Mota, Ana Paula
    Alves Rios, Danyelle Romana
    SantAna Dusse, Luci Maria
    CLINICA CHIMICA ACTA, 2015, 440 : 36 - 39
  • [3] Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
    Tain, You-Lin
    Hsu, Chien-Ning
    TOXINS, 2017, 9 (03):
  • [4] Homoarginine in the shadow of asymmetric dimethylarginine: from nitric oxide to cardiovascular disease
    Papageorgiou, Nikolaos
    Androulakis, Emmanuel
    Papaioannou, Spyridon
    Antoniades, Charalambos
    Tousoulis, Dimitris
    AMINO ACIDS, 2015, 47 (09) : 1741 - 1750
  • [5] The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
    Sibal, Latika
    Agarwal, Sharad C.
    Home, Philip D.
    Boger, Rainer H.
    CURRENT CARDIOLOGY REVIEWS, 2010, 6 (02) : 82 - 90
  • [6] Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
    Hsu, Chien-Ning
    Tain, You-Lin
    CHILDREN-BASEL, 2021, 8 (10):
  • [7] Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk
    Boeger, Rainer H.
    Maas, Renke
    Schulze, Friedrich
    Schwedhelm, Edzard
    PHARMACOLOGICAL RESEARCH, 2009, 60 (06) : 481 - 487
  • [8] Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
    Oliva-Damaso, Elena
    Oliva-Damaso, Nestor
    Rodriguez-Esparragon, Francisco
    Payan, Juan
    Maranes, Alberto
    Parodis, Yanet
    Eduardo Baamonde-Laborda, Lopez
    Vega Diaz, Nicanor
    Carlos Rodriguez-Perez, Jose
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (02): : 165 - 171
  • [9] Effect of asymmetric dimethylarginine (ADMA) on heart failure development
    Liu, Xiaoyu
    Hou, Lei
    Xu, Dachun
    Chen, Angela
    Yang, Liuqing
    Zhuang, Yan
    Xu, Yawei
    Fassett, John T.
    Chen, Yingjie
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2016, 54 : 73 - 81
  • [10] Asymmetric dimethylarginine: predictor of cardiovascular diseases?
    Nemeth Balazs
    Kustan Peter
    Nemeth Adam
    Lenkey Zsofia
    Cziraki Attila
    Kiss Istvan
    Sulyok Endre
    Ajtay Zeno
    ORVOSI HETILAP, 2016, 157 (13) : 483 - 487
12345